TGFB1 and neoplasm: Tumor-promoting signaling molecules including transforming growth factor-β (TGF-β), IL-10, IDO, and VEGF inhibited tumor antigen presentation, as well as activation, proliferation, differentiation, and cytotoxicity of T cells, thereby limiting the efficacy of anti-tumor immunity [48].